A New Supplement for the Immune Response to HPV Infection

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate whether a supplement in which ellagic acid plus annona muricata are combined, may modulate the immune response to high risk HPV infection. Sixty women will be enrolled in a randomized, controlled study, having a histological diagnosis of L-SIL correlated with high rish HPV types infection. Main outcome measure is the activation of onco suppressor protein by the supplement and secondary outcome is the clearance of HPV infection in the treated group.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02263378
Study type	Interventional
Source	University of Messina
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04098744` - Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)	Phase 2
Completed	`NCT04083196` - A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years	Phase 1
Completed	`NCT04191967` - Thermocoagulation for Treatment of Precancerous Cervical Lesions	N/A
Withdrawn	`NCT04430907` - HPV Vaccine in Postpartum Women
Recruiting	`NCT02593968` - Yallaferon in Chinese Population	Phase 2
Completed	`NCT04711265` - Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys
Completed	`NCT05234112` - Prevention and Screening Towards Elimination of Cervical Cancer	N/A
Completed	`NCT04590521` - HPV Vaccine Immunity in High-risk Women	Phase 4
Recruiting	`NCT05829629` - Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women	Phase 1
Recruiting	`NCT06052033` - Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection	N/A
Recruiting	`NCT05051852` - HPV Viral Load in Predicting the Prognosis of LSIL
Completed	`NCT04155294` - Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV
Completed	`NCT06177236` - Clinic or Self-Sampling for Cervical Cancer Screening	N/A
Active, not recruiting	`NCT04794660` - The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"	Phase 3
Recruiting	`NCT05509413` - DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections	N/A
Recruiting	`NCT06137950` - Interferon Alpha Therapy for Cervical CINI and HPV Infection	Phase 1
Recruiting	`NCT04171505` - Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.
Active, not recruiting	`NCT05524025` - The SPOT-HPV Study
Recruiting	`NCT04998318` - 1:1 Comparison of the Pocket Colposcope in Kenya	N/A
Not yet recruiting	`NCT06129253` - Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)